Lao People's Democratic Republic

Lao People's Democratic Republic

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
8.66 (7.32 - 10) 2019 Modelled IHME
8.7 (7.44 - 10.03) 2018 Modelled IHME
8.79 (7.39 - 10.35) 2017 Modelled IHME
9.07 (7.75 - 10.48) 2016 Modelled IHME
9.42 (8.03 - 10.93) 2015 Modelled IHME
9.64 (8.18 - 11.14) 2014 Modelled IHME
9.82 (8.30 - 11.33) 2013 Modelled IHME
9.98 (8.39 - 11.59) 2012 Modelled IHME
10.15 (8.44 - 11.88) 2011 Modelled IHME
10.33 (8.57 - 12.23) 2010 Modelled IHME
10.56 (8.74 - 12.45) 2009 Modelled IHME
10.82 (8.98 - 12.66) 2008 Modelled IHME
11.08 (9.21 - 12.96) 2007 Modelled IHME
11.3 (9.39 - 13.28) 2006 Modelled IHME
11.44 (9.50 - 13.52) 2005 Modelled IHME
11.51 (9.62 - 13.52) 2004 Modelled IHME
11.57 (9.66 - 13.53) 2003 Modelled IHME
11.61 (9.66 - 13.69) 2002 Modelled IHME
11.66 (9.72 - 13.79) 2001 Modelled IHME
11.72 (9.74 - 13.92) 2000 Modelled IHME
11.81 (9.85 - 14.05) 1999 Modelled IHME
11.93 (9.96 - 14.18) 1998 Modelled IHME
12.05 (10.06 - 14.30) 1997 Modelled IHME
12.15 (10.13 - 14.43) 1996 Modelled IHME
12.18 (10.12 - 14.56) 1995 Modelled IHME
12.17 (10.12 - 14.42) 1994 Modelled IHME
12.11 (10.04 - 14.27) 1993 Modelled IHME
12.02 (9.93 - 14.12) 1992 Modelled IHME
11.9 (9.79 - 13.94) 1991 Modelled IHME
11.74 (9.57 - 13.81) 1990 Modelled IHME
4.81 (3.74 - 5.99) 2015 Modelled WHO
3.7 (3.30 - 4.60) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.11 (1.56 - 2.69) 2019 Modelled IHME
2.21 (1.66 - 2.83) 2018 Modelled IHME
2.3 (1.69 - 2.97) 2017 Modelled IHME
2.37 (1.76 - 3.03) 2016 Modelled IHME
2.46 (1.80 - 3.14) 2015 Modelled IHME
2.59 (1.92 - 3.27) 2014 Modelled IHME
2.77 (2.07 - 3.49) 2013 Modelled IHME
2.99 (2.25 - 3.78) 2012 Modelled IHME
3.25 (2.46 - 4.12) 2011 Modelled IHME
3.53 (2.66 - 4.54) 2010 Modelled IHME
3.89 (2.92 - 4.99) 2009 Modelled IHME
4.36 (3.29 - 5.62) 2008 Modelled IHME
4.89 (3.66 - 6.35) 2007 Modelled IHME
5.44 (4.05 - 7.14) 2006 Modelled IHME
5.99 (4.41 - 7.96) 2005 Modelled IHME
6.6 (4.93 - 8.60) 2004 Modelled IHME
7.31 (5.48 - 9.45) 2003 Modelled IHME
8 (5.95 - 10.44) 2002 Modelled IHME
8.56 (6.43 - 11.24) 2001 Modelled IHME
8.88 (6.58 - 11.71) 2000 Modelled IHME
9.03 (6.85 - 11.82) 1999 Modelled IHME
9.17 (6.97 - 11.92) 1998 Modelled IHME
9.27 (7.13 - 11.99) 1997 Modelled IHME
9.34 (7.17 - 11.97) 1996 Modelled IHME
9.36 (7.09 - 12.13) 1995 Modelled IHME
9.35 (7.18 - 12.10) 1994 Modelled IHME
9.32 (7.11 - 12.09) 1993 Modelled IHME
9.26 (6.98 - 12.05) 1992 Modelled IHME
9.17 (6.78 - 12.04) 1991 Modelled IHME
9.05 (6.57 - 12.05) 1990 Modelled IHME
1.94 (1.34 - 2.73) 2015 Modelled WHO
1.7 (0.80 - 2.60) 2012 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
487,239 (397,122 - 573,302) 1990 Modelled IHME
508,378 (418,338 - 595,768) 1991 Modelled IHME
528,727 (436,703 - 620,977) 1992 Modelled IHME
547,170 (453,507 - 644,492) 1993 Modelled IHME
563,587 (468,893 - 668,227) 1994 Modelled IHME
578,890 (480,631 - 691,951) 1995 Modelled IHME
591,965 (493,961 - 703,330) 1996 Modelled IHME
602,113 (502,663 - 714,472) 1997 Modelled IHME
610,653 (509,783 - 725,653) 1998 Modelled IHME
618,767 (516,267 - 736,326) 1999 Modelled IHME
627,753 (522,090 - 746,016) 2000 Modelled IHME
638,001 (531,945 - 754,873) 2001 Modelled IHME
648,314 (539,394 - 764,480) 2002 Modelled IHME
657,762 (549,108 - 769,594) 2003 Modelled IHME
665,975 (556,581 - 782,163) 2004 Modelled IHME
673,303 (559,322 - 795,509) 2005 Modelled IHME
676,934 (562,523 - 795,298) 2006 Modelled IHME
674,740 (561,000 - 789,329) 2007 Modelled IHME
668,770 (554,827 - 782,326) 2008 Modelled IHME
661,830 (547,936 - 780,510) 2009 Modelled IHME
656,445 (544,377 - 777,336) 2010 Modelled IHME
653,473 (543,319 - 764,844) 2011 Modelled IHME
651,404 (547,833 - 756,457) 2012 Modelled IHME
649,175 (548,605 - 749,365) 2013 Modelled IHME
645,643 (548,041 - 746,277) 2014 Modelled IHME
639,602 (544,981 - 741,963) 2015 Modelled IHME
624,065 (533,317 - 721,065) 2016 Modelled IHME
612,710 (515,251 - 721,616) 2017 Modelled IHME
614,622 (525,629 - 708,561) 2018 Modelled IHME
619,985 (523,917 - 715,713) 2019 Modelled IHME
251,000 (226,000 - 310,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.25 (5.05 - 10) 2019 Modelled IHME
7.34 (5.13 - 10.10) 2018 Modelled IHME
7.45 (5.14 - 10.30) 2017 Modelled IHME
7.53 (5.23 - 10.30) 2016 Modelled IHME
7.65 (5.36 - 10.40) 2015 Modelled IHME
7.77 (5.50 - 10.60) 2014 Modelled IHME
7.89 (5.64 - 10.70) 2013 Modelled IHME
8.03 (5.74 - 10.80) 2012 Modelled IHME
8.18 (5.93 - 10.90) 2011 Modelled IHME
8.26 (6.04 - 10.80) 2010 Modelled IHME
8.29 (6.07 - 10.80) 2009 Modelled IHME
8.29 (6.13 - 10.70) 2008 Modelled IHME
8.28 (6.18 - 10.60) 2007 Modelled IHME
8.32 (6.20 - 10.60) 2006 Modelled IHME
8.4 (6.27 - 10.80) 2005 Modelled IHME
8.52 (6.41 - 10.90) 2004 Modelled IHME
8.73 (6.59 - 11.10) 2003 Modelled IHME
9.04 (6.71 - 11.50) 2002 Modelled IHME
9.45 (7.03 - 12) 2001 Modelled IHME
9.82 (7.32 - 12.50) 2000 Modelled IHME
10.3 (7.71 - 13.20) 1999 Modelled IHME
10.6 (7.98 - 13.60) 1998 Modelled IHME
10.9 (8.13 - 14.20) 1997 Modelled IHME
11.3 (8.31 - 14.60) 1996 Modelled IHME
11.6 (8.53 - 15.30) 1995 Modelled IHME
11.8 (8.62 - 15.70) 1994 Modelled IHME
12.1 (8.79 - 16.10) 1993 Modelled IHME
12.3 (8.85 - 16.50) 1992 Modelled IHME
12.5 (8.94 - 16.90) 1991 Modelled IHME
12.7 (9.02 - 17.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
519 (361 - 719) 2019 Modelled IHME
518 (363 - 713) 2018 Modelled IHME
519 (358 - 721) 2017 Modelled IHME
518 (360 - 706) 2016 Modelled IHME
519 (364 - 706) 2015 Modelled IHME
521 (369 - 708) 2014 Modelled IHME
522 (373 - 706) 2013 Modelled IHME
524 (374 - 704) 2012 Modelled IHME
527 (382 - 701) 2011 Modelled IHME
525 (384 - 687) 2010 Modelled IHME
519 (381 - 675) 2009 Modelled IHME
512 (379 - 664) 2008 Modelled IHME
504 (376 - 646) 2007 Modelled IHME
499 (372 - 636) 2006 Modelled IHME
494 (369 - 633) 2005 Modelled IHME
493 (371 - 628) 2004 Modelled IHME
497 (375 - 632) 2003 Modelled IHME
505 (375 - 641) 2002 Modelled IHME
517 (385 - 659) 2001 Modelled IHME
526 (392 - 672) 2000 Modelled IHME
538 (404 - 690) 1999 Modelled IHME
544 (409 - 696) 1998 Modelled IHME
547 (406 - 708) 1997 Modelled IHME
549 (405 - 714) 1996 Modelled IHME
551 (405 - 725) 1995 Modelled IHME
548 (399 - 726) 1994 Modelled IHME
545 (397 - 726) 1993 Modelled IHME
540 (389 - 727) 1992 Modelled IHME
533 (382 - 724) 1991 Modelled IHME
526 (375 - 714) 1990 Modelled IHME
1,366 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
42 (33 - 51) 2019 Modelled IHME
42 (33 - 51) 2018 Modelled IHME
42 (33 - 52) 2017 Modelled IHME
43 (34 - 52) 2016 Modelled IHME
43 (34 - 53) 2015 Modelled IHME
43 (35 - 53) 2014 Modelled IHME
43 (35 - 53) 2013 Modelled IHME
44 (35 - 53) 2012 Modelled IHME
44 (35 - 54) 2011 Modelled IHME
44 (35 - 54) 2010 Modelled IHME
44 (36 - 54) 2009 Modelled IHME
45 (36 - 55) 2008 Modelled IHME
45 (36 - 55) 2007 Modelled IHME
45 (36 - 55) 2006 Modelled IHME
45 (36 - 55) 2005 Modelled IHME
45 (36 - 55) 2004 Modelled IHME
45 (36 - 55) 2003 Modelled IHME
45 (36 - 55) 2002 Modelled IHME
45 (36 - 55) 2001 Modelled IHME
44 (35 - 55) 2000 Modelled IHME
44 (35 - 55) 1999 Modelled IHME
44 (35 - 55) 1998 Modelled IHME
44 (35 - 55) 1997 Modelled IHME
44 (35 - 55) 1996 Modelled IHME
44 (35 - 55) 1995 Modelled IHME
44 (35 - 55) 1994 Modelled IHME
44 (35 - 55) 1993 Modelled IHME
44 (35 - 55) 1992 Modelled IHME
44 (35 - 55) 1991 Modelled IHME
44 (35 - 56) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
55 2018 Survey/reported WHO/UNICEF
55 2017 Survey/reported WHO/UNICEF
55 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
68 2018 Survey/reported WHO/UNICEF
69 2017 Survey/reported WHO/UNICEF
66 2016 Survey/reported WHO/UNICEF
81 2015 Survey/reported WHO/UNICEF
88 2014 Survey/reported WHO/UNICEF
87 2013 Survey/reported WHO/UNICEF
79 2012 Survey/reported WHO/UNICEF
78 2011 Survey/reported WHO/UNICEF
74 2010 Survey/reported WHO/UNICEF
67 2009 Survey/reported WHO/UNICEF
61 2008 Survey/reported WHO/UNICEF
50 2007 Survey/reported WHO/UNICEF
57 2006 Survey/reported WHO/UNICEF
49 2005 Survey/reported WHO/UNICEF
45 2004 Survey/reported WHO/UNICEF
50 2003 Survey/reported WHO/UNICEF
68 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2004
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.58 (2.07 - 3.22) 2019 Modelled IHME
2.58 (2.08 - 3.23) 2018 Modelled IHME
2.58 (2.07 - 3.22) 2017 Modelled IHME
2.56 (2.06 - 3.16) 2016 Modelled IHME
2.54 (2.03 - 3.14) 2015 Modelled IHME
2.52 (2.02 - 3.11) 2014 Modelled IHME
2.5 (2.01 - 3.08) 2013 Modelled IHME
2.47 (2 - 3.06) 2012 Modelled IHME
2.46 (1.99 - 3.04) 2011 Modelled IHME
2.45 (1.98 - 3.04) 2010 Modelled IHME
2.46 (1.99 - 3.05) 2009 Modelled IHME
2.49 (2 - 3.08) 2008 Modelled IHME
2.53 (2.03 - 3.12) 2007 Modelled IHME
2.57 (2.07 - 3.17) 2006 Modelled IHME
2.61 (2.09 - 3.23) 2005 Modelled IHME
2.65 (2.12 - 3.28) 2004 Modelled IHME
2.68 (2.15 - 3.31) 2003 Modelled IHME
2.72 (2.18 - 3.35) 2002 Modelled IHME
2.76 (2.21 - 3.39) 2001 Modelled IHME
2.8 (2.24 - 3.44) 2000 Modelled IHME
2.84 (2.27 - 3.50) 1999 Modelled IHME
2.87 (2.31 - 3.55) 1998 Modelled IHME
2.91 (2.34 - 3.59) 1997 Modelled IHME
2.94 (2.36 - 3.67) 1996 Modelled IHME
2.97 (2.37 - 3.71) 1995 Modelled IHME
3 (2.40 - 3.75) 1994 Modelled IHME
3.02 (2.41 - 3.77) 1993 Modelled IHME
3.04 (2.43 - 3.79) 1992 Modelled IHME
3.06 (2.44 - 3.83) 1991 Modelled IHME
3.08 (2.44 - 3.84) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
127,672 (101,224 - 159,507) 1990 Modelled IHME
130,708 (104,203 - 163,534) 1991 Modelled IHME
133,689 (106,709 - 166,495) 1992 Modelled IHME
136,372 (108,871 - 170,107) 1993 Modelled IHME
138,769 (111,370 - 173,757) 1994 Modelled IHME
141,146 (112,709 - 176,107) 1995 Modelled IHME
143,403 (115,024 - 178,938) 1996 Modelled IHME
145,373 (116,809 - 179,481) 1997 Modelled IHME
147,132 (118,121 - 181,854) 1998 Modelled IHME
148,701 (118,765 - 183,473) 1999 Modelled IHME
150,104 (120,270 - 184,550) 2000 Modelled IHME
151,277 (120,861 - 185,243) 2001 Modelled IHME
152,126 (121,811 - 187,132) 2002 Modelled IHME
152,659 (122,372 - 188,389) 2003 Modelled IHME
153,031 (122,761 - 189,591) 2004 Modelled IHME
153,579 (122,971 - 189,966) 2005 Modelled IHME
154,019 (123,937 - 190,157) 2006 Modelled IHME
154,010 (123,745 - 189,955) 2007 Modelled IHME
153,949 (123,701 - 190,199) 2008 Modelled IHME
154,396 (124,802 - 190,968) 2009 Modelled IHME
155,837 (125,781 - 193,048) 2010 Modelled IHME
158,345 (128,161 - 196,096) 2011 Modelled IHME
161,514 (130,552 - 199,660) 2012 Modelled IHME
165,108 (132,745 - 203,853) 2013 Modelled IHME
168,870 (135,192 - 208,292) 2014 Modelled IHME
172,530 (137,841 - 212,959) 2015 Modelled IHME
176,474 (142,059 - 217,638) 2016 Modelled IHME
179,951 (144,608 - 224,212) 2017 Modelled IHME
182,474 (146,643 - 227,968) 2018 Modelled IHME
184,785 (148,056 - 230,356) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.02 (4.06 - 8.40) 2019 Modelled IHME
5.93 (3.95 - 8.30) 2018 Modelled IHME
5.85 (3.90 - 8.28) 2017 Modelled IHME
5.7 (3.87 - 7.97) 2016 Modelled IHME
5.58 (3.79 - 7.72) 2015 Modelled IHME
5.45 (3.74 - 7.54) 2014 Modelled IHME
5.3 (3.61 - 7.27) 2013 Modelled IHME
5.18 (3.54 - 7.16) 2012 Modelled IHME
5.12 (3.52 - 6.85) 2011 Modelled IHME
5.09 (3.54 - 6.81) 2010 Modelled IHME
5.09 (3.56 - 6.75) 2009 Modelled IHME
5.09 (3.60 - 6.72) 2008 Modelled IHME
5.09 (3.63 - 6.75) 2007 Modelled IHME
5.12 (3.67 - 6.76) 2006 Modelled IHME
5.17 (3.75 - 6.84) 2005 Modelled IHME
5.21 (3.76 - 6.85) 2004 Modelled IHME
5.31 (3.82 - 7.07) 2003 Modelled IHME
5.45 (3.92 - 7.23) 2002 Modelled IHME
5.64 (4.07 - 7.55) 2001 Modelled IHME
5.82 (4.21 - 7.80) 2000 Modelled IHME
6.05 (4.36 - 8.17) 1999 Modelled IHME
6.24 (4.46 - 8.36) 1998 Modelled IHME
6.4 (4.55 - 8.73) 1997 Modelled IHME
6.57 (4.66 - 8.98) 1996 Modelled IHME
6.74 (4.73 - 9.19) 1995 Modelled IHME
6.86 (4.83 - 9.49) 1994 Modelled IHME
6.98 (4.85 - 9.73) 1993 Modelled IHME
7.08 (4.90 - 9.82) 1992 Modelled IHME
7.19 (4.98 - 10) 1991 Modelled IHME
7.29 (4.99 - 10.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
431 (290 - 601) 2019 Modelled IHME
419 (279 - 586) 2018 Modelled IHME
408 (272 - 577) 2017 Modelled IHME
393 (266 - 548) 2016 Modelled IHME
379 (257 - 524) 2015 Modelled IHME
365 (251 - 505) 2014 Modelled IHME
350 (239 - 481) 2013 Modelled IHME
338 (231 - 467) 2012 Modelled IHME
330 (226 - 442) 2011 Modelled IHME
324 (225 - 433) 2010 Modelled IHME
319 (223 - 423) 2009 Modelled IHME
315 (222 - 415) 2008 Modelled IHME
310 (221 - 411) 2007 Modelled IHME
307 (220 - 405) 2006 Modelled IHME
304 (220 - 402) 2005 Modelled IHME
301 (218 - 396) 2004 Modelled IHME
302 (217 - 402) 2003 Modelled IHME
304 (219 - 404) 2002 Modelled IHME
309 (223 - 413) 2001 Modelled IHME
312 (226 - 418) 2000 Modelled IHME
317 (228 - 428) 1999 Modelled IHME
319 (228 - 428) 1998 Modelled IHME
320 (227 - 436) 1997 Modelled IHME
320 (227 - 438) 1996 Modelled IHME
320 (225 - 437) 1995 Modelled IHME
318 (224 - 440) 1994 Modelled IHME
315 (219 - 440) 1993 Modelled IHME
312 (215 - 432) 1992 Modelled IHME
307 (213 - 427) 1991 Modelled IHME
303 (207 - 422) 1990 Modelled IHME
343 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
24 (17 - 31) 2018 Modelled IHME
24 (17 - 32) 2017 Modelled IHME
24 (17 - 31) 2016 Modelled IHME
24 (17 - 31) 2015 Modelled IHME
24 (17 - 31) 2014 Modelled IHME
24 (17 - 31) 2013 Modelled IHME
24 (17 - 31) 2012 Modelled IHME
24 (17 - 31) 2011 Modelled IHME
24 (17 - 31) 2010 Modelled IHME
24 (17 - 31) 2009 Modelled IHME
24 (17 - 31) 2008 Modelled IHME
24 (17 - 31) 2007 Modelled IHME
24 (17 - 32) 2006 Modelled IHME
24 (17 - 32) 2005 Modelled IHME
24 (17 - 32) 2004 Modelled IHME
24 (17 - 32) 2003 Modelled IHME
24 (17 - 32) 2002 Modelled IHME
24 (17 - 32) 2001 Modelled IHME
24 (17 - 33) 2000 Modelled IHME
24 (17 - 33) 1999 Modelled IHME
25 (17 - 33) 1998 Modelled IHME
25 (17 - 33) 1997 Modelled IHME
25 (17 - 33) 1996 Modelled IHME
25 (17 - 33) 1995 Modelled IHME
25 (17 - 33) 1994 Modelled IHME
25 (17 - 33) 1993 Modelled IHME
25 (17 - 33) 1992 Modelled IHME
25 (17 - 33) 1991 Modelled IHME
25 (17 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2004
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
519
2019
(361 - 719)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
431
2019
(290 - 601)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
55 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines